ALK-Abelló A/S
ALK-B
Rangering i aksjer
#2433
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Aksjekurs
$36.23
Sist synkronisert: 2026-10-16
Markedsverdi
$8.04B
Endring (1 dag)
-1.72%
Endring (1 år)
12.00%
Land
DK
Handel ALK-Abelló A/S (ALK-B)
Kategori
Healthcare
Markedsverdi av ALK-Abelló A/S(ALK-B)
Markedsverdi: $8.04B
Per October 2026 har ALK-Abelló A/S en markedsverdi på $8.04B. Dette gjør ALK-Abelló A/S til det 2433rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for ALK-Abelló A/S fra 2009 til 2026
ALK-B sammenlignet med topp 5 mest populære stocks
